Santen Pharmaceutical Co., Ltd. (SNPHY)
11.39
+0.20
(+1.76%)
USD |
OTCM |
Oct 26, 16:00
Santen Pharmaceutical Enterprise Value : 3.361B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.361B |
| October 23, 2026 | 3.297B |
| October 22, 2026 | 3.162B |
| October 21, 2026 | 3.300B |
| October 20, 2026 | 3.352B |
| October 19, 2026 | 3.239B |
| October 16, 2026 | 3.203B |
| October 15, 2026 | 3.185B |
| October 14, 2026 | 3.207B |
| October 13, 2026 | 3.216B |
| October 12, 2026 | 3.021B |
| October 09, 2026 | 3.138B |
| October 08, 2026 | 3.124B |
| October 07, 2026 | 3.137B |
| October 06, 2026 | 2.989B |
| October 05, 2026 | 3.133B |
| October 02, 2026 | 3.092B |
| October 01, 2026 | 3.275B |
| September 30, 2026 | 3.186B |
| September 29, 2026 | 3.090B |
| September 28, 2026 | 3.203B |
| September 25, 2026 | 3.252B |
| September 24, 2026 | 3.156B |
| September 23, 2026 | 3.191B |
| September 22, 2026 | 3.239B |
| Date | Value |
|---|---|
| September 21, 2026 | 3.217B |
| September 18, 2026 | 3.265B |
| September 17, 2026 | 3.378B |
| September 16, 2026 | 3.140B |
| September 15, 2026 | 3.291B |
| September 14, 2026 | 3.296B |
| September 11, 2026 | 3.323B |
| September 10, 2026 | 3.211B |
| September 09, 2026 | 3.453B |
| September 08, 2026 | 3.397B |
| September 04, 2026 | 3.471B |
| September 03, 2026 | 3.541B |
| September 02, 2026 | 3.310B |
| September 01, 2026 | 3.413B |
| August 31, 2026 | 3.561B |
| August 28, 2026 | 3.509B |
| August 27, 2026 | 3.455B |
| August 26, 2026 | 3.641B |
| August 25, 2026 | 3.485B |
| August 24, 2026 | 3.487B |
| August 21, 2026 | 3.509B |
| August 20, 2026 | 3.685B |
| August 19, 2026 | 3.535B |
| August 18, 2026 | 3.578B |
| August 17, 2026 | 3.689B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 92.14B |
| Daiichi Sankyo Co., Ltd. | 31.72B |
| Eisai Co., Ltd. | 9.067B |
| Chugai Pharmaceutical Co., Ltd. | 65.89B |
| Ono Pharmaceutical Co., Ltd. | 6.783B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 45.18M |
| Revenue (Quarterly) | 432.73M |
| Total Expenses (Quarterly) | 387.58M |
| EPS Diluted (Quarterly) | 0.1399 |
| Gross Profit Margin (Quarterly) | 54.66% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 6.74% |
| Operating Earnings Yield | 7.88% |